Development of a clinical decision tool to reduce diagnostic testing for primary aldosteronism in patients with difficult-to-control hypertension
Open Access
- 29 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Endocrine Disorders
- Vol. 20 (1), 1-8
- https://doi.org/10.1186/s12902-020-0528-3
Abstract
Satisfactory tools to preclude low-risk patients from intensive diagnostic testing for primary aldosteronism (PA) are lacking. Therefore, we aimed to develop a decision tool to determine which patients with difficult-to-control hypertension have a low probability of PA, thereby limiting the exposure to invasive testing while at the same time increasing the efficiency of testing in the remaining patients. Data from consecutive patients with difficult-to-control hypertension, analysed through a standardized diagnostic protocol between January 2010 and October 2017 (n = 824), were included in this cross-sectional study. PA was diagnosed by a combined approach: 1) elevated aldosterone-to-renin ratio (> 5.0 pmol/fmol/s), confirmed with 2) non-suppressible aldosterone after standardized saline infusion (≥280 pmol/L). Multivariable logistic regression analyses including seven pre-specified clinical variables (age, systolic blood pressure, serum potassium, potassium supplementation, serum sodium, eGFR and HbA1c) was performed. After correction for optimism, test reliability, discriminative performance and test characteristics were determined. PA was diagnosed in 40 (4.9%) of 824 patients. Predicted probabilities of PA agreed well with observed frequencies and the c-statistic was 0.77 (95% confidence interval (95%CI) 0.70–0.83). Predicted probability cut-off values of 1.0–2.5% prevented unnecessary testing in 8–32% of the patients with difficult-to-control hypertension, carrying sensitivities of 0.98 (95%CI 0.96–0.99) and 0.92 (0.83–0.97), and negative predictive values of 0.99 (0.98–1.00) and 0.99 (0.97–0.99). With a decision tool, based on seven easy-to-measure clinical variables, patients with a low probability of PA can be reliably selected and a considerable proportion of patients with difficult-to-control hypertension can be spared intensive diagnostic testing.Keywords
This publication has 26 references indexed in Scilit:
- Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronismJournal of Hypertension, 2014
- Automated detection of sleep disordered breathing using a nasal pressure monitoring deviceSleep and Breathing, 2008
- Multiple imputation of discrete and continuous data by fully conditional specificationStatistical Methods in Medical Research, 2007
- Prevalence of Primary Aldosteronism among Unselected Hypertensive Patients: A Prospective Study Based on the Use of an Aldosterone/Renin Ratio above 25 as a Screening TestHypertension Research, 2007
- A Prospective Study of the Prevalence of Primary Aldosteronism in 1,125 Hypertensive PatientsJournal of the American College of Cardiology, 2006
- Review: A gentle introduction to imputation of missing valuesJournal of Clinical Epidemiology, 2006
- Renal Damage in Primary AldosteronismHypertension, 2006
- Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocolJournal of Hypertension, 2006
- Prognostic Modeling with Logistic Regression AnalysisMedical Decision Making, 2001
- A Screening Test to Identify Aldosterone-Producing Adenoma by Measuring Plasma Renin ActivityArchives of Internal Medicine, 1981